The Population Council, Inc.

The US Food and Drug Administration’s imminent action on Biogen Pharma and Eisai Co., Ltd. ’s Alzheimer’s drug aducanumab is bound to be controversial, regardless of whether the agency approves the

The US Food and Drug Administration’s decision to grant conditional approval to Biogen Pharma and Eisai Co., Ltd. ’s Alzheimer’s drug aducanumab has been met with mixed responses. Questions about t

US FDA announced the approval of two new forms of birth control on Aug. 10, including the first mobile medical app to be cleared for that purpose in the US. The app, Natural Cycles , uses an algorith

The US FDA maintained a torrid approval pace, capping the week with three novel approvals on Friday Aug. 10 to bring the Center for Drug Evaluation and Research’s (CDER's) annual count to 30. Orphan d